40
Participants
Start Date
June 30, 2014
Primary Completion Date
December 31, 2014
Study Completion Date
December 31, 2014
PF-06743649
40 mg tablet one time once with a meal and once without a meal, followed by once daily dosing for 14 days
Placebo
Placebo tablet one time once with a meal and once without a meal, followed by once daily dosing for 14 days
PF-06743649
To be decided dose, tablet once daily dosing for 14 days
Placebo
Placebo tablet once daily dosing for 14 days
PF-06743649
To be decided dose, tablet, one time once with a meal and once without a meal, followed by once daily dosing for 14 days
Placebo
Placebo tablet one time once with a meal and once without a meal, followed by once daily dosing for 14 days
PF-06743649
To be decided dose, tablet, one time without a meal, followed by once daily dosing for 14 days
Placebo
Placebo tablet one time once without a meal, followed by once daily dosing for 14 days
PF-06743649
Tablet, to be decided dose, once daily, 14 days
Placebo
Tablet, once daily, 14 days
New Haven Clinical Research Unit, New Haven
Lead Sponsor
Pfizer
INDUSTRY